Inhibition of the terminal stages of adipocyte differentiation by cMyc
Inhibition of the terminal stages of adipocyte differentiation by cMyc
复制标题
DOI:
10.1006/excr.1999.4736
复制
发表时间:
2000-01-10
影响因子:
3.7
通讯作者:
Crouch, DH
中科院分区:
文献类型:
--
作者:
Heath, VJ;Gillespie, DAF;Crouch, DH
The nuclear oncoprotein Myc is a pivotal regulator of several important biological processes, including cellular proliferation, differentiation, and apoptosis, Deregulated Myc expression is incompatible with terminal differentiation in a variety of cell types, including adipocytes, To understand how Myc inhibits adipogenesis, we analyzed the effect of Myc on the expression of genes characteristic of distinct phases of the hormonally induced adipogenic differentiation program in 3T3-L1 preadipocytes. We show that the early regulators, C/EBP beta and C/EBP delta, are induced normally in response to hormone in 3T3-L1 preadipocytes constitutively expressing Myc, but that expression of the downstream regulators, C/EBP alpha and PPAR gamma 2, and later markers of differentiation is suppressed. These data demonstrate that Myc specifically inhibits the terminal stages of the adipogenic program and suggest that Myc may act by blocking C/EBP beta- and C/EBP delta-directed activation of C/EBP alpha and PPAR gamma 2 expression, although the precise molecular mechanism is not understood. Surprisingly, a serum component(s) could override the Myc-induced differentiation block, suggesting that the ability of a cell to undergo terminal differentiation is governed by the action of both positive and negative factors. Since differentiation and proliferation are mutually exclusive events, this has important implications since it may be possible to force malignant cells along a differentiation pathway, thereby curbing their proliferative potential. (C) 2000 Academic Press.